A Study of Amantadine for Cognitive Dysfunction in Patients With Long-Covid
Conditions: Long COVID; Post-Acute COVID-19 Syndrome Interventions: Drug: Amantadine; Other: Physical, Occupational, Speech Therapy; Other: Provider Counseling; Other: Medications for symptoms management Sponsors: University of Texas Southwestern Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Amantadine | COVID-19 | Occupational Health | Research | Speech Therapy | Speech-Language Pathology | Study | Symmetrel | Texas University